Viatris reports Q3 adjusted EPS 67c, consensus 62c

Reports Q3 revenue $3.75B, consensus $3.6B. “We delivered another strong quarter by staying focused on our 2025 strategic priorities,” said Scott A. Smith, Chief Executive Officer, Viatris (VTRS). “Our performance this quarter reflects the continued strength of our execution across markets. We are advancing our pipeline with key regulatory submissions and preparing for multiple potential launches, while preparing to take meaningful actions through our enterprise-wide strategic review to position Viatris for sustainable growth in 2026 and beyond. We remain confident in our strategy, our people, and our ability to deliver significant impact for patients and long-term value for shareholders.”